Form 4: Voyager Therapeutics CFO Nathan Jorgensen Receives Stock Options as Employment Inducement

Nathan Jorgensen, CFO of Voyager Therapeutics, was granted stock options as an inducement to join the company.

Summary

• On July 8, 2024, Nathan D. Jorgensen, the Chief Financial Officer of Voyager Therapeutics, Inc., was granted stock options to purchase 200,000 shares of common stock.
• The options were granted as an inducement material to Jorgensen entering into employment with the company, in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
• The exercise price of the options is $7.79 per share.
• The options vest over four years, with 1/4th vesting on the one-year anniversary of the grant date and an additional 1/48th vesting monthly thereafter, contingent upon continued employment.
• The options expire on July 8, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and indicates confidence in the new CFO. It also aligns the CFO's interests with those of the shareholders.

Positives

• The granting of stock options to a key executive like the CFO can align their interests with those of the shareholders, incentivizing them to improve company performance.
• The vesting schedule encourages long-term commitment from the CFO.

Industry Context

Granting stock options to new executives is a common practice in the biotechnology industry to attract and retain talent. These grants are often structured to align the executive's interests with the long-term success of the company.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Biogen, Amgen, and Gilead Sciences also use stock options to incentivize their executives.
• The size of the grant (200,000 shares) and the vesting schedule (four years with a one-year cliff) are fairly typical for a CFO-level position in a company of Voyager Therapeutics' size and stage.

Management Changes

Stakeholder Impact

• Shareholders: The granting of stock options aligns the CFO's interests with those of the shareholders, potentially leading to increased shareholder value.
• Employees: The addition of a new CFO can impact employee morale and strategic direction.
• Customers: No direct impact on customers is apparent from this announcement.

Key Dates